Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells.
暂无分享,去创建一个
Choa Park | Choa Park | Youngjoo Lee | Youngjoo Lee | Kwanghee Ryu | K. Ryu
[1] R. Hill,et al. Hypoxia and Metastasis , 2007, Clinical Cancer Research.
[2] Victor X Jin,et al. Loss of Estrogen Receptor Signaling Triggers Epigenetic Silencing of Downstream Targets in Breast Cancer , 2004, Cancer Research.
[3] Adrian V. Lee,et al. Proteasome inhibition represses ERα gene expression in ER+ cells- a new link between proteasome activity and estrogen signaling in breast cancer , 2009, Oncogene.
[4] D. Coradini,et al. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens , 2003, Cellular and Molecular Life Sciences CMLS.
[5] J. Simons,et al. Hypoxia-inducible factor-1 in human breast and prostate cancer. , 2006, Endocrine-related cancer.
[6] S. Ellison-Zelski,et al. Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter , 2009, Molecular and Cellular Biology.
[7] Jiannis Ragoussis,et al. Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts , 2009, The Journal of Biological Chemistry.
[8] Youngjoo Lee,et al. Cobalt Chloride-Induced Estrogen Receptor α Down-Regulation Involves Hypoxia-Inducible Factor-1α in MCF-7 Human Breast Cancer Cells , 2005 .
[9] Emmanuel Chamorey,et al. HIF‐1α and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome , 2007 .
[10] J. Pouysségur,et al. Oxygen, a source of life and stress , 2007, FEBS letters.
[11] R. Schiff,et al. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk. , 2006, Endocrine-related cancer.
[12] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[13] Youngjoo Lee,et al. Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells. , 2005, Molecular endocrinology.
[14] Nan Li,et al. Human Phosphatidylethanolamine-binding Protein 4 Promotes Transactivation of Estrogen Receptor α (ERα) in Human Cancer Cells by Inhibiting Proteasome-dependent ERα Degradation via Association with Src* , 2010, The Journal of Biological Chemistry.
[15] P. V. van Diest,et al. Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related , 2004, Breast Cancer Research.
[16] S. Safe,et al. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. , 2002, Molecular endocrinology.
[17] Yusuke Nakamura,et al. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. , 2009, Cancer research.
[18] M. Shupnik,et al. ERβ in breast cancer—Onlooker, passive player, or active protector? , 2008, Steroids.
[19] E. Alarid,et al. Amping up estrogen receptors in breast cancer , 2007, Breast Cancer Research.
[20] Diego Villar,et al. Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction , 2010, Nucleic acids research.
[21] Emmanuel Chamorey,et al. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. , 2007, International journal of cancer.
[22] Jiannis Ragoussis,et al. Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition , 2006, Journal of Biological Chemistry.
[23] Naz Chaudary,et al. Hypoxia and metastasis in breast cancer. , 2006, Breast disease.
[24] H. Iwase,et al. Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer , 2008, Breast Cancer Research and Treatment.
[25] L. Murphy,et al. Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[26] J. Pouysségur,et al. Hypoxia and cancer , 2007, Journal of Molecular Medicine.
[27] N. Colburn,et al. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion , 2010, Oncogene.